Literature DB >> 7061729

Clobazam kinetics: intrasubject variability and effect of food on adsorption.

M Divoll, D J Greenblatt, D A Ciraulo, S K Puri, I Ho, R I Shader.   

Abstract

The kinetics of single 20-mg oral doses of clobazam was determined on two occasions in 12 healthy male volunteers. Clobazam was given in the fasting state on one occasion and following a standard breakfast on another. Compared with the fasting state, administration of clobazam with food reduced mean peak plasma concentrations (465 vs. 333 ng/ml, P less than 0.01), and prolonged the time to reach peak concentration (1.7 vs. 2.5 hours after dosage, P less than 0.1). Total area under the curve nor the extent of formation of desmethylclobazam, the major metabolite. Clobazam AUC and elimination half-life each were highly correlated within subjects between the two trials (r = 0.97 and 0.95, respectively). Thus, administration of clobazam with food slows the rate of clobazam absorption but does not alter the completeness of absorption. The rate of drug elimination is highly replicable upon repeated administration clobazam to the same individual.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061729     DOI: 10.1002/j.1552-4604.1982.tb05711.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  11 in total

1.  The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state.

Authors:  J M Scavone; D J Greenblatt; J E Goddard; H Friedman; J S Harmatz; R I Shader
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis.

Authors:  J Sennesael; D Verbeelen; L Vanhaelst; R Pirola; S R Bareggi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors:  Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal:  Ther Drug Monit       Date:  2013-02       Impact factor: 3.681

4.  PharmGKB summary: clobazam pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Steven Leeder; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2018-04       Impact factor: 2.089

Review 5.  Clobazam.

Authors:  Yu-tze Ng; Stephen D Collins
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

6.  Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.

Authors:  S Jawad; A Richens; J Oxley
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 7.  Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.

Authors:  G Chouinard; K Lefko-Singh; E Teboul
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 8.  Clinical pharmacokinetics of the newer benzodiazepines.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; H R Ochs; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

Review 9.  [Benzodiazepines: significance of kinetics for therapy].

Authors:  H R Ochs
Journal:  Klin Wochenschr       Date:  1983-03-01

10.  A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and children.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  Pharm Res       Date:  2014-07-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.